Susquehanna International Group
WST icon

Susquehanna International Group’s West Pharmaceutical WST Stock Holding History

Susquehanna International Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.1M Buy
36,300
+19,800
+120% +$4.93M ﹤0.01% 3260
2025
Q4 		$4.54M Sell
16,500
-27,200
-62% -$7.44M ﹤0.01% 4181
2025
Q3 		$11.5M Sell
43,700
-24,000
-35% -$5.83M ﹤0.01% 2872
2025
Q2 		$14.8M Sell
67,700
-21,400
-24% -$4.57M ﹤0.01% 2353
2025
Q1 		$19.9M Buy
89,100
+28,700
+48% +$7.91M ﹤0.01% 1744
2024
Q4 		$19.8M Buy
60,400
+13,800
+30% +$4.34M ﹤0.01% 1870
2024
Q3 		$14M Sell
46,600
-79,400
-63% -$24.3M ﹤0.01% 2193
2024
Q2 		$41.5M Buy
126,000
+89,600
+246% +$31.7M 0.01% 1111
2024
Q1 		$14.4M Buy
36,400
+200
+0.6% +$74K ﹤0.01% 2149
2023
Q4 		$12.7M Buy
36,200
+2,200
+6% +$779K ﹤0.01% 2329
2023
Q3 		$12.8M Sell
34,000
-600
-2% -$232K ﹤0.01% 2254
2023
Q2 		$13.2M Sell
34,600
-11,700
-25% -$4.18M ﹤0.01% 2158
2023
Q1 		$16M Sell
46,300
-30,100
-39% -$8.8M ﹤0.01% 1921
2022
Q4 		$18M Buy
76,400
+45,000
+143% +$10.7M ﹤0.01% 1634
2022
Q3 		$7.73M Sell
31,400
-8,400
-21% -$2.56M ﹤0.01% 2518
2022
Q2 		$12M Sell
39,800
-5,800
-13% -$1.89M ﹤0.01% 1976
2022
Q1 		$18.7M Sell
45,600
-11,500
-20% -$4.5M ﹤0.01% 1799
2021
Q4 		$26.8M Buy
57,100
+14,800
+35% +$6.37M ﹤0.01% 1567
2021
Q3 		$18M Buy
42,300
+2,900
+7% +$1.22M ﹤0.01% 2094
2021
Q2 		$14.1M Sell
39,400
-3,800
-9% -$1.26M ﹤0.01% 2439
2021
Q1 		$12.2M Sell
43,200
-2,400
-5% -$687K ﹤0.01% 2485
2020
Q4 		$12.9M Buy
45,600
+35,900
+370% +$10.1M ﹤0.01% 2199
2020
Q3 		$2.67M Sell
9,700
-4,400
-31% -$1.16M ﹤0.01% 4080
2020
Q2 		$3.2M Buy
14,100
+5,200
+58% +$1.02M ﹤0.01% 3696
2020
Q1 		$1.35M Buy
8,900
+6,600
+287% +$1.02M ﹤0.01% 4704
2019
Q4 		$346K Sell
2,300
-121,900
-98% -$17.7M ﹤0.01% 7735
2019
Q3 		$17.6M Buy
124,200
+46,000
+59% +$6.33M 0.01% 1439
2019
Q2 		$9.79M Buy
78,200
+29,300
+60% +$3.46M ﹤0.01% 1908
2019
Q1 		$5.39M Buy
48,900
+1,900
+4% +$198K ﹤0.01% 2360
2018
Q4 		$4.61M Buy
47,000
+42,900
+1,046% +$4.65M ﹤0.01% 2374
2018
Q3 		$506K Buy
4,100
+400
+11% +$44.9K ﹤0.01% 6503
2018
Q2 		$367K Buy
+3,700
New +$341K ﹤0.01% 7446
2018
Q1 		– Sell
-8,200
Closed -$809K – 10295
2017
Q4 		$809K Buy
+8,200
New +$804K ﹤0.01% 5666
2014
Q3 		– Sell
-6,100
Closed -$257K – 10010
2014
Q2 		$257K Sell
6,100
-2,100
-26% -$89.9K ﹤0.01% 8649
2014
Q1 		$361K Buy
+8,200
New +$386K ﹤0.01% 7302

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's WST Position: Q1 2026 in Review

Susquehanna International Group reduced its West Pharmaceutical (WST) stake by 55% in Q1 2026, selling an estimated $2.43M and leaving 7,926 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6192.

Susquehanna International Group first reported a position in WST in Q2 2013 and has held it in 45 quarters since. The position peaked at $27.4M in Q3 2023. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Susquehanna International Group held 7,926 shares of West Pharmaceutical worth $1.99M as of Q1 2026.
  • Susquehanna International Group sold 9,758 West Pharmaceutical shares in Q1 2026, an estimated $2.43M.
  • West Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6192 holding.
  • Susquehanna International Group first reported a position in West Pharmaceutical in Q2 2013 and has held it in 45 quarters since.
  • Susquehanna International Group's West Pharmaceutical position peaked at $27.4M in Q3 2023.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.